109 related articles for article (PubMed ID: 18268082)
21. Tailoring amphotericin B as an ionic liquid: an upfront strategy to potentiate the biological activity of antifungal drugs.
Hartmann DO; Shimizu K; Rothkegel M; Petkovic M; Ferraz R; Petrovski Ž; Branco LC; Canongia Lopes JN; Silva Pereira C
RSC Adv; 2021 Apr; 11(24):14441-14452. PubMed ID: 35423994
[No Abstract] [Full Text] [Related]
22. Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on
Palmieri F; Koutsokera A; Bernasconi E; Junier P; von Garnier C; Ubags N
Front Med (Lausanne); 2022; 9():832510. PubMed ID: 35386908
[TBL] [Abstract][Full Text] [Related]
23. Antifungal Macrocycle Antibiotic Amphotericin B-Its Present and Future. Multidisciplinary Perspective for the Use in the Medical Practice.
Baghirova AA; Kasumov KM
Biochem Mosc Suppl B Biomed Chem; 2022; 16(1):1-12. PubMed ID: 35194486
[TBL] [Abstract][Full Text] [Related]
24. The Elevated Endogenous Reactive Oxygen Species Contribute to the Sensitivity of the Amphotericin B-Resistant Isolate of
Liang T; Chen W; Yang X; Wang Q; Wan Z; Li R; Liu W
Front Microbiol; 2021; 12():680749. PubMed ID: 34413836
[No Abstract] [Full Text] [Related]
25. The Environmental Spread of
Dietl AM; Vahedi-Shahandashti R; Kandelbauer C; Kraak B; Lackner M; Houbraken J; Lass-Flörl C
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33808004
[TBL] [Abstract][Full Text] [Related]
26. Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections.
Cavassin FB; Baú-Carneiro JL; Vilas-Boas RR; Queiroz-Telles F
Infect Dis Ther; 2021 Mar; 10(1):115-147. PubMed ID: 33523419
[TBL] [Abstract][Full Text] [Related]
27. Amphotericin B and Other Polyenes-Discovery, Clinical Use, Mode of Action and Drug Resistance.
Carolus H; Pierson S; Lagrou K; Van Dijck P
J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33261213
[TBL] [Abstract][Full Text] [Related]
28.
Page L; Ullmann AJ; Schadt F; Wurster S; Samnick S
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393491
[TBL] [Abstract][Full Text] [Related]
29. The potency of luliconazole against clinical and environmental
Hivary S; Fatahinia M; Halvaeezadeh M; Mahmoudabadi AZ
Iran J Microbiol; 2019 Dec; 11(6):510-519. PubMed ID: 32148683
[TBL] [Abstract][Full Text] [Related]
30. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
31. An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection.
Mortaz E; Sarhifynia S; Marjani M; Moniri A; Mansouri D; Mehrian P; van Leeuwen K; Roos D; Garssen J; Adcock IM; Tabarsi P
BMC Infect Dis; 2018 Nov; 18(1):552. PubMed ID: 30409207
[TBL] [Abstract][Full Text] [Related]
32. Widespread amphotericin B-resistant strains of
Ashu EE; Korfanty GA; Samarasinghe H; Pum N; You M; Yamamura D; Xu J
Infect Drug Resist; 2018; 11():1549-1555. PubMed ID: 30288065
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Infections Due to
Lass-Flörl C
J Fungi (Basel); 2018 Jul; 4(3):. PubMed ID: 29987241
[TBL] [Abstract][Full Text] [Related]
34. Varying susceptibility of clinical and environmental Scedosporium isolates to chemical oxidative stress in conidial germination.
Staerck C; Godon C; Bouchara JP; Fleury MJJ
Arch Microbiol; 2018 Apr; 200(3):517-523. PubMed ID: 29464281
[TBL] [Abstract][Full Text] [Related]
35. The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases.
Schwartz IS; Patterson TF
Curr Infect Dis Rep; 2018 Feb; 20(3):2. PubMed ID: 29404711
[TBL] [Abstract][Full Text] [Related]
36. Invasive
Bengyella L; Yekwa EL; Subhani MN; Tambo E; Nawaz K; Hetsa BA; Iftikhar S; Waikhom SD; Roy P
Infect Drug Resist; 2017; 10():425-436. PubMed ID: 29158685
[TBL] [Abstract][Full Text] [Related]
37. Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.
Shekhova E; Kniemeyer O; Brakhage AA
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848005
[TBL] [Abstract][Full Text] [Related]
38. Proteomics as a Tool to Identify New Targets Against Aspergillus and Scedosporium in the Context of Cystic Fibrosis.
Ramirez-Garcia A; Pellon A; Buldain I; Antoran A; Arbizu-Delgado A; Guruceaga X; Rementeria A; Hernando FL
Mycopathologia; 2018 Feb; 183(1):273-289. PubMed ID: 28484941
[TBL] [Abstract][Full Text] [Related]
39. Study on Antioxidant Enzymatic Activities of
Zhang Y; Li H; Yang R; Wang C
Indian J Microbiol; 2016 Dec; 56(4):445-450. PubMed ID: 27784941
[TBL] [Abstract][Full Text] [Related]
40. Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.
Mesa-Arango AC; Rueda C; Román E; Quintin J; Terrón MC; Luque D; Netea MG; Pla J; Zaragoza O
Antimicrob Agents Chemother; 2016 Apr; 60(4):2326-35. PubMed ID: 26833156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
